C-Level Forum Speakers:

Ajan Reginald   , Chief Executive Officer,   Celixir

Alain Vertès   , Managing Director,   NxR Biotechnologies

Alex Pemberton   , Programme Manager UKRMP,   Medical Research Council

André Choulika   , Chairman & Chief Executive Officer,   Cellectis

Andrea Piccin, Consultant Haematologist   , Haematology Dept & BMT Unit,   San Maurizio Regional Hospital Bolzano
Bob Harman  
, CEO,   VetStem Biopharma, Inc.

Benjamin Shepherd   , Director, Therapeutics,   Organovo

Chaim Lebovits   , CEO,   Brainstorm Cell Therapeutics

Christoph Neyer   , ‎Director Business Development,   InGeneron GmbH

Claudia Mitchell   , CEO,   Universal Cells, Inc.

Damien Bates   , Chief Medical Officer & Head of Research,   SanBio

David Pettitt   , Research Associate, Centre for the Advancement of Sustainable Medical Innovation (CASMI), DPhil Candidate, Medical Sciences, University of Oxford

Didier Caizergues   , Head of Regulatory Affairs Department,   Genethon

Diego Ardigò   , Project Lead,   Chiesi Group

Eduardo Bravo   , Managing Director and CEO,   TiGenix

Eric Soller   , Vice President of Corporate Development & Strategy,   BlueRock Therapeutics

Gerry Graham   , Head, Chemokine Research Group & Deputy Head of the Institute of Infection, Immunity and Inflammation,   University of Glasgow 

Giovanna Lombardi   , Professor, Human Transplant Immunology, Transplantation Immunology & Mucosal Biology, MRC Centre for Transplantation,   King’s College London (KCL)

Giulia Detela   , Process Design Manager,   VivaBioCell S.p.A.

Giuseppe Mazza   , Chief Executive & Scientific Officer,   Engitix 

Ian Campbell   , Director for Health and Life Sciences,   Innovate UK 

James Miskin   , Chief Technical Officer,   Oxford BioMedica

James Noble   , CEO,   Adaptimmune

Jane Lebkowski   , ‎President of R&D,   Asterias Biotherapeutics

Jeff Abbey   , CEO,   Argos Therapeutics

Jeffrey Schaffer   , Director of Veterinary Professional Services,   VetStem

John Campbell   , Associate Director, Research, Development & Innovation, SNBTS,   National Science Laboratory

John Tchelingerian   , CEO, Promethera,   Biosciences

Katy Spink   , Chief Operating Officer,   Asterias Biotherapeutics

Kristin Comella   , Chief Science Officer,   US Stem Cell Inc.

Marc Turner   , Medical Director,   SNBTS

Margo Roberts   , CSO,   Kite Pharma

Mark Zimmerman   , Vice President, Business Development and Strategy,   ViaCyte

Mehis Pilv   , Cofounder and Managing Director,   GeneCode Ltd

Michael Stein   , Chairman & CEO,   Oxstem

Michael West   , CEO,   BioTime;   CEO ,   AgeX Therapeutics

Michele Lipucci   , CAT Full Member,   Patients’ representative, EMA

Nick Crabb   , Programme Director – Scientific Affairs,   NICE

Norio Nakatsuji, Founding Director   , Institute for Integrated Cell-Material Sciences (iCeMS),   Kyoto University, Kyoto, Japan

Ohad Karnieli   , Chair, Process and Product Development Subcommittee,   ISCT   ; CEO & Co-Founder,   ATVIO 

Pascale V Guillot   , Head of the Cellular Reprogramming & Perinatal Therapy Team,   Institute for Women’s Health UCL

Paul Peter Tak   , Professor of Medicine, Rheumatology, Academic Medical Center,   University of Amsterdam AMC   (Senior Vice President of Research and Development Pipeline and Chief Immunology Officer,   GSK   & Board Member,   Galvani   )

Peder Olofsson   , Leader, Center for Bioelectronic Medicine, Department of Medicine,   Karolinska Institutet

Qasim Rafiq   , Senior Lecturer in Bioprocessing of Regenerative, Cellular and Gene Therapy,   UCL

Roger Smith   , Professor, Equine Orthopaedics,   Royal Veterinary College (RVC)

Stephen Badylak   , Professor, Department of Surgery, Deputy Director of the McGowan Institute for Regenerative Medicine (MIRM), & Director, Center for Pre-Clinical Tissue Engineering within the Institute

Susan Solomon   , CEO and Co-Founder,   New York Stem Cell Foundation

Suzanne S. Farid   , Professor of Bioprocess Systems Engineering,   UCL

Todd McAllister   , Executive Director,   Amnion Foundation

Václav Procházka   , Deputy Director for Science & Research,   University Hospital Ostrava

Yen Choo   , CEO,   Progenitor Therapeutics

Zami Aberman   , Chairman & CEO,   Pluristem Therapeutics

Representative from Cellgenix

Representative from ThermoFisher

Representative from Cryoport

Representative from Terumo

Representative from Fujifilm Diosynth

Representative from Maxcyte

Representative from Merck

Representative from Novo Nordisk Pharmatech

Representative from PCT Cell Therapy Services

 

CHECK THE AGENDA OVERVIEW:

**Full agenda to be unveiled on 1st December !** 
 

 

The World Precision Medicine Congress is both a world-class conference, bringing together hundreds of pharma, biotech and academic leaders from around the globe, and a fantastic exhibition showcasing the newest technologies, developments and solutions. There is a registration fee to attend the congress, however the exhibition is absolutely free to attend .

CONTACT US
phone: +44 (0)207 092 1134
email:
 
joan.shutt@terrapinn.com